IL33 and cardiac hypertrophy: For example, in the heart, IL-33 has been shown to antagonize angiotensin II- and epinephrine-induced cardiomyocyte hypertrophy, and ST2-knockout mice exhibit increased ventricular hypertrophy, more severe fibrosis, and impaired survival.